Table 2 Initial site of recurrence and outcomes of the patients who presented with disease recurrence during follow-up
No | Age | Histology | FIGO | Response to treatment | Recurrent and metastases | Treatment Compliance | Current situation | ||
|---|---|---|---|---|---|---|---|---|---|
(y) | Stage | Post NACT | Post CCRT | PFS a (m) | Region | (Reason) | OS a (m) | ||
1 | 66 | SC | IIIC1r | SD | CR | 31 | Lymphatic metastases (para-aortic and left diaphragmatic foot) | / | Alive (39) |
2 | 54 | SC | IIIC1r | SD | PD | 7 | Metastases in the lung and mesentery | Reduced cisplatin cycle concurrent with radiotherapy to 3 (hepatic insufficiency) | Dead (12) |
3 | 40 | SC | IIIC1r | SD | PR | 20 | Metastases in the pelvis | / | Dead (31) |
4 | 53 | SC | IIB | PR | CR | 12 | Lymphatic metastases (para-aortic and parailiac vascular) | Reduced NACT cycle to 3 (myelosuppression) Discontinued brachytherapy (grade 4 neutropenia that could not be improved) | Alive (25) |
5 | 35 | SC | IIIC1r | SD | PD | 6 | Lymphatic metastases (left collarbone, para-aortic, parailiac vascular) and liver metastases | / | Dead (10) |
6 | 60 | ASC | IIIC2r | CR | CR | 13 | Local recurrence and lymphatic metastases (para-aortic, pelvic and inguinal) | / | Alive (19) |
7 | 57 | SC | IIIC1r | SD | PD | 7 | Metastases in the lung, mesentery and lymphonodus (inguinal) | Delayed beginning of chemoradiation (grade 4 neutropenia with high fever) | Alive (15) |
8 | 66 | SC | IIIC2r | PR | CR | 10 | Metastases in the vagina | / | Dead (12) |
9 | 43 | SC | IIIC2r | SD | PD | 6 | Metastases in the lung and mesentery | Reduced cisplatin cycle concurrent with radiotherapy to 3 (thrombocytopenia) Postponed brachytherapy for 2Â weeks (a large amount of vaginal bleeding with severe anemia and thrombocytopenia) | Dead (14) |
10 | 50 | SC | IIIC1r | PR | PD | 6 | Metastases in the vagina | Delayed beginning of chemoradiation (grade 4 hepatic insufficiency) | Alive (10) |